BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, Hamblin MR, Mirzaei H. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Crit Rev Oncol Hematol 2021;157:103192. [PMID: 33290823 DOI: 10.1016/j.critrevonc.2020.103192] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Jafari SH, Rabiei N, Taghizadieh M, Mirazimi SMA, Kowsari H, Farzin MA, Razaghi Bahabadi Z, Rezaei S, Mohammadi AH, Alirezaei Z, Dashti F, Nejati M. Joint application of biochemical markers and imaging techniques in the accurate and early detection of glioblastoma. Pathol Res Pract 2021;224:153528. [PMID: 34171601 DOI: 10.1016/j.prp.2021.153528] [Reference Citation Analysis]
2 Jiang L, Wang Y, Tang H, Li X, Huang C, Liu Z, Zhou F, Wang X, Li Y. CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer. Front Genet 2021;12:663982. [PMID: 34234808 DOI: 10.3389/fgene.2021.663982] [Reference Citation Analysis]
3 Cabus U, Secme M, Kabukcu C, Cil N, Dodurga Y, Mete G, Fenkci IV. Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms. Gene 2021;796-797:145799. [PMID: 34175401 DOI: 10.1016/j.gene.2021.145799] [Reference Citation Analysis]
4 Zheng J, Chen L. Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge. Biomed Pharmacother 2021;146:112123. [PMID: 34915417 DOI: 10.1016/j.biopha.2021.112123] [Reference Citation Analysis]
5 Sun H, Wu Z, Liu M, Yu L, Li J, Zhang J, Ding X, Jin H. CircRNA May Not Be "Circular". Front Genet 2021;12:633750. [PMID: 33679895 DOI: 10.3389/fgene.2021.633750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang Y, Li Y, Qi R, Zhang L. Constructe a novel 5 hypoxia genes signature for cervical cancer. Cancer Cell Int 2021;21:345. [PMID: 34217310 DOI: 10.1186/s12935-021-02050-3] [Reference Citation Analysis]
7 Huang Z, Li F, Li Q. Expression profile of RNA binding protein in cervical cancer using bioinformatics approach. Cancer Cell Int 2021;21:647. [PMID: 34863153 DOI: 10.1186/s12935-021-02319-7] [Reference Citation Analysis]
8 Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, Malik S, Kumar L, Kar S, Singh SK, Upadhye VJ, Iqbal D, Almojam S, Roychoudhury S, Ojha S, Ruokolainen J, Jha NK, Kesari KK. Mechanistic Role of HPV-Associated Early Proteins in Cervical Cancer: Molecular Pathways and Targeted Therapeutic Strategies. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103675] [Reference Citation Analysis]
9 Sun R, Liu W, Zhao Y, Chen H, Wang Z, Zhang Y, Sun X, Cui X. Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage. Cancer Cell Int 2021;21:311. [PMID: 34120606 DOI: 10.1186/s12935-021-02011-w] [Reference Citation Analysis]
10 Barwal TS, Sharma U, Rana MK, Bazala S, Singh I, Murmu M, Kapoor HS, Thakur S, Jain M, Jain A. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in Thyroid, Pancreatic and Ovarian Cancer. Crit Rev Oncol Hematol 2022;:103598. [PMID: 35033662 DOI: 10.1016/j.critrevonc.2022.103598] [Reference Citation Analysis]
11 Jiang J, Gao G, Pan Q, Liu J, Tian Y, Zhang X. Circular RNA circHIPK3 is downregulated in diabetic cardiomyopathy and overexpression of circHIPK3 suppresses PTEN to protect cardiomyocytes from high glucose-induced cell apoptosis. Bioengineered 2022;13:6272-9. [PMID: 35200097 DOI: 10.1080/21655979.2022.2031395] [Reference Citation Analysis]
12 Aishanjiang K, Wei XD, Fu Y, Lin X, Ma Y, Le J, Han Q, Wang X, Kong X, Gu J, Wu H. Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles. Front Oncol 2021;11:653717. [PMID: 33959506 DOI: 10.3389/fonc.2021.653717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sun W, Zhou H, Han X, Hou L, Xue X. Circular RNA: A novel type of biomarker for glioma (Review). Mol Med Rep 2021;24:602. [PMID: 34165178 DOI: 10.3892/mmr.2021.12240] [Reference Citation Analysis]
14 Zheng J, Guo J, Zhang H, Cao B, Xu G, Zhang Z, Tong J. Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer. Front Genet 2021;12:672674. [PMID: 34367239 DOI: 10.3389/fgene.2021.672674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Fan HP, Zhu ZX, Xu JJ, Li YT, Guo CW, Yan H. The lncRNA CASC9 alleviates lipopolysaccharide-induced acute kidney injury by regulating the miR-424-5p/TXNIP pathway. J Int Med Res 2021;49:3000605211037495. [PMID: 34407684 DOI: 10.1177/03000605211037495] [Reference Citation Analysis]
16 Ran Z, Wu S, Ma Z, Chen X, Liu J, Yang J. Advances in exosome biomarkers for cervical cancer. Cancer Med 2022. [PMID: 35578572 DOI: 10.1002/cam4.4828] [Reference Citation Analysis]
17 Badie F, Ghandali M, Tabatabaei SA, Safari M, Khorshidi A, Shayestehpour M, Mahjoubin-Tehran M, Morshedi K, Jalili A, Tajiknia V, Hamblin MR, Mirzaei H. Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches. Front Oncol 2021;11:624759. [PMID: 33738260 DOI: 10.3389/fonc.2021.624759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gao M, Cui Z, Li S, Li N, Tong L, Wang Y, Song M, Zhou B, Yin Z. Survival Outcome and Clinicopathologicl analysis of Homeobox gene cluster-embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis. Expert Rev Mol Diagn 2021;21:1211-21. [PMID: 34410213 DOI: 10.1080/14737159.2021.1970536] [Reference Citation Analysis]
19 Huang L, Rong Y, Tang X, Yi K, Wu J, Wang F. Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer. Front Mol Biosci 2021;8:625722. [PMID: 34136531 DOI: 10.3389/fmolb.2021.625722] [Reference Citation Analysis]
20 Liu C, Barger CJ, Karpf AR. FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer. Cancers (Basel) 2021;13:3065. [PMID: 34205406 DOI: 10.3390/cancers13123065] [Reference Citation Analysis]
21 Maleki B, Alani B, Tamehri Zadeh SS, Saadat S, Rajabi A, Ayoubzadeh SMJ, Verdi J, Farrokhian A, Ghanbarian H, Noureddini M, Nejati M. MicroRNAs and exosomes: Cardiac stem cells in heart diseases. Pathol Res Pract 2021;229:153701. [PMID: 34872024 DOI: 10.1016/j.prp.2021.153701] [Reference Citation Analysis]
22 Lou W, Wang W, Chen J, Wang S, Huang Y. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;24:845-55. [PMID: 34026328 DOI: 10.1016/j.omtn.2021.03.014] [Reference Citation Analysis]
23 Liu L, Fang F, Lu X. Long Noncoding RNA Mediated Regulation in Human Embryogenesis, Pluripotency, and Reproduction. Stem Cells International 2022;2022:1-19. [DOI: 10.1155/2022/8051717] [Reference Citation Analysis]
24 Carrero YN, Callejas DE, Mosquera JA. In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review. Transl Oncol 2021;14:101058. [PMID: 33677234 DOI: 10.1016/j.tranon.2021.101058] [Reference Citation Analysis]
25 Zhang H, He P, Zhou Q, Lu Y, Lu B. The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells. Cancer Cell Int 2021;21:369. [PMID: 34247597 DOI: 10.1186/s12935-021-02078-5] [Reference Citation Analysis]
26 Xu P, Ma Y, Wu H, Wang YL. Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy. Front Cell Dev Biol 2021;9:646326. [PMID: 33777951 DOI: 10.3389/fcell.2021.646326] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cavaliere AF, Perelli F, Zaami S, Piergentili R, Mattei A, Vizzielli G, Scambia G, Straface G, Restaino S, Signore F. Towards Personalized Medicine: Non-Coding RNAs and Endometrial Cancer. Healthcare (Basel) 2021;9:965. [PMID: 34442102 DOI: 10.3390/healthcare9080965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Yang L, Li J, Li S, Dang W, Xin S, Long S, Zhang W, Cao P, Lu J. Extracellular Vesicles Regulated by Viruses and Antiviral Strategies. Front Cell Dev Biol 2021;9:722020. [PMID: 34746122 DOI: 10.3389/fcell.2021.722020] [Reference Citation Analysis]
29 Wei J, Gao Y, Li Z, Jia H, Han B. LncRNA SNHG6 facilitates cell proliferation, migration, invasion and EMT by upregulating UCK2 and activating the Wnt/β-catenin signaling in cervical cancer. Bioorg Chem 2021;120:105488. [PMID: 35033815 DOI: 10.1016/j.bioorg.2021.105488] [Reference Citation Analysis]
30 Causin RL, Freitas AJA, Trovo Hidalgo Filho CM, Reis RD, Reis RM, Marques MMC. A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression. Cells 2021;10:668. [PMID: 33803022 DOI: 10.3390/cells10030668] [Reference Citation Analysis]
31 Khan S, Jha A, Panda AC, Dixit A. Cancer-Associated circRNA-miRNA-mRNA Regulatory Networks: A Meta-Analysis. Front Mol Biosci 2021;8:671309. [PMID: 34055888 DOI: 10.3389/fmolb.2021.671309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Wu C, Song W, Wang Z, Wang B. Functions of lncRNA DUXAP8 in non-small cell lung cancer. Mol Biol Rep 2022. [PMID: 35031926 DOI: 10.1007/s11033-021-07066-6] [Reference Citation Analysis]
33 Piergentili R, Zaami S, Cavaliere AF, Signore F, Scambia G, Mattei A, Marinelli E, Gulia C, Perelli F. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int J Mol Sci 2021;22:3151. [PMID: 33808791 DOI: 10.3390/ijms22063151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wang A, Xu Q, Sha R, Bao T, Xi X, Guo G. MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer. Oncol Lett 2021;21:272. [PMID: 33717269 DOI: 10.3892/ol.2021.12533] [Reference Citation Analysis]
35 Hernández-Aguilar AI, Luciano-Villa CA, Tello-Flores VA, Beltrán-Anaya FO, Zubillaga-Guerrero MI, Flores-Alfaro E. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. Expert Rev Mol Diagn 2021;21:809-21. [PMID: 34133256 DOI: 10.1080/14737159.2021.1944808] [Reference Citation Analysis]
36 Zhao Y, Sun Y, Yang J, Zhu Z, Jia X. WITHDRAWN: Circ_0000517 contributes to hepatocellular carcinoma progression by upregulating ARID4B via sponging miR-328-3p. Cell Signal 2021;:109950. [PMID: 33582185 DOI: 10.1016/j.cellsig.2021.109950] [Reference Citation Analysis]
37 Liu R, Wang X, Shen Y, He A. Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations. Mol Biol Rep 2021;48:2713-27. [PMID: 33704659 DOI: 10.1007/s11033-021-06247-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Zhi Y, Gao L, Wang B, Ren W, Liang KX, Zhi K. Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs. Front Cell Dev Biol 2021;9:686906. [PMID: 34235152 DOI: 10.3389/fcell.2021.686906] [Reference Citation Analysis]
39 Wang Q, Xu B, Liu H, Wang D, Liu S, He C, Feng X, Wang L. CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR-153-3p/ATF2 axis and wnt/β-catenin pathway. Drug Dev Res 2022. [PMID: 34981843 DOI: 10.1002/ddr.21908] [Reference Citation Analysis]